Centiva Capital, LP Moderna, Inc. Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

A detailed history of Centiva Capital, LP transactions in Moderna, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 4,568 shares of MRNA stock, worth $168,330. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,568

Previous 3,600 26.89%

Holding current value

$168,330

Previous $427,000 28.57%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $318 - $625	-5 Reduced 0.11%	4,568 $305,000
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $462,833 - $761,907	4,573 New	4,573 $543,000
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $44,694 - $67,148	643 Added 233.82%	918 $91,000
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $1.75 Million - $2.29 Million	-18,112 Reduced 98.5%	275 $28,000
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $976,677 - $1.32 Million	8,242 Added 81.24%	18,387 $2.23 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $761,459 - $1.11 Million	-5,613 Reduced 35.62%	10,145 $1.56 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $447,476 - $793,951	-3,780 Reduced 19.35%	15,758 $2.83 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $2.21 Million - $3.64 Million	18,728 Added 2312.1%	19,538 $2.31 Million
Q2 2022 Aug 17, 2022	SELL	$117.13 - $176.59 $22.7 Million - $34.3 Million	-194,200 Reduced 99.58%	810 $116,000
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $18.8 Million - $28.4 Million	160,626 Added 467.15%	195,010 $27.9 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $4.19 Million - $7.79 Million	33,155 Added 2697.72%	34,384 $5.92 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $3.48 Million - $7.6 Million	-15,693 Reduced 92.74%	1,229 $473,000
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $1.85 Million - $3.15 Million	16,922 New	16,922 $2.22 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $224,587 - $392,015	-4,133 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $122,626 - $330,640	4,133 New	4,133 $265,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account

Centiva Capital, LP Moderna, Inc. Transaction History